Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Tender offer successful: Bayer acquires majority interest in Conceptus -- 96.4 percent of Conceptus' shares tendered -- Conceptus imminently to become a wholly-owned Bayer subsidiary PR...
Antitrust clearance obtained for Bayer's acquisition of Conceptus Offer expires at midnight on June 4/5, 2013 PR Newswire LEVERKUSEN, Germany and WAYNE, N.J., May 29, 2013...
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Conceptus, Inc...
Bayer commences cash tender offer for all outstanding shares of Conceptus, Inc. PR Newswire LEVERKUSEN, Germany and WAYNE, N.J., May 7, 2013 LEVERKUSEN, Germany and WAYNE, N.J., May 7, 2013...
NEW YORK, May 6, 2013 (GLOBE NEWSWIRE) -- Levi & Korsinsky notifies investors of Conceptus, Inc. ("Conceptus" or the "Company") (Nasdaq:CPTS) of claims of breaches of fiduciary duty and other...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Conceptus, Inc. in Connection with the Sale of the Company to Bayer...
Law Offices of Howard G. Smith announces that it is investigating potential claims against the Board of Directors of Conceptus, Inc. (“Conceptus” or the “Company”) (NASDAQ:CPTS) related to...
Rigrodsky & Long, P.A.: Do you own shares of Conceptus, Inc. (NASDAQ GS: CPTS)? Did you purchase any of your shares prior to April 29, 2013? Do you think the proposed buyout...
Komlossy Law, P.A. is investigating the Board of Directors of Conceptus, Inc. (“Conceptus” or the “Company”) (Nasdaq:CPTS) for possible breaches of fiduciary duty and other violations of...
Levi & Korsinsky is investigating the Board of Directors of Conceptus, Inc. (“Conceptus” or the “Company”) (NasdaqGS: CPTS) for possible breaches of fiduciary duty and other violations of...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
